Edoceo Devices - Viral and Bacterial Detection Revenue and Competitors
Estimated Revenue & Valuation
- Edoceo Devices - Viral and Bacterial Detection's estimated annual revenue is currently $775k per year.
- Edoceo Devices - Viral and Bacterial Detection's estimated revenue per employee is $155,000
Employee Data
- Edoceo Devices - Viral and Bacterial Detection has 5 Employees.
- Edoceo Devices - Viral and Bacterial Detection grew their employee count by -17% last year.
Edoceo Devices - Viral and Bacterial Detection's People
Name | Title | Email/Phone |
---|
Edoceo Devices - Viral and Bacterial Detection Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 11 | 0% | N/A | N/A |
#2 | $2.8M | 18 | 13% | N/A | N/A |
#3 | $70.2M | 453 | -1% | N/A | N/A |
#4 | $1.6M | 10 | -66% | N/A | N/A |
#5 | $3.7M | 24 | -8% | N/A | N/A |
#6 | $2.9M | 37 | 28% | N/A | N/A |
#7 | $3.1M | 20 | 25% | N/A | N/A |
#8 | $2.5M | 16 | -20% | N/A | N/A |
#9 | $9.1M | 59 | 0% | N/A | N/A |
#10 | $4.2M | 27 | -7% | N/A | N/A |
What Is Edoceo Devices - Viral and Bacterial Detection?
Edoceo Devices is an emerging med-tech & biotech American company with Exclusive and Groundbreaking Biosensor Technology that could Help in the fight against COVID-19 – as well as Future Viral and Bacterial Threats to our normal family way of life. The priority is finalizing the development and marketing of this technology to produce two on-site proprietary detection biosensors - with the goal of providing essential rapid early warning to the presence of harmful pathogens: • Edoceo B-DetectTM - A portable virulent bacterial Testing device • Edoceo V-DetectTM - A portable virus biosensing device Edoceo B-Detect and V-Detect have the potential to change the world of rapid, portable, affordable, and accurate testing for pathogens including virulent bacteria and the presence of a range of viruses. These innovative detection platforms are being developed for the aquaculture, veterinary, health care, food processing and home monitoring markets, amongst others – Edoceo detection devices are based on the work of their Chief Science Officer, the Multi-Award-Winning Dr. Kenneth Reardon, in collaboration with many years of study and research by the scientists at Colorado State University that is exclusively licensed to Edoceo. *Breaking News* As a potential bonus to investors, and having secured substantial access to supplies, Edoceo Devices are commencing commercialization of a rapid (< 17 minutes), simple, saliva-based antigen test for the Coronavirus – Edoceo A-Detect which is already CE marked for distribution in the European Union and we are also planning a US FDA Emergency Use Application for distribution and sales in the United States.
keywords:N/AN/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 5 | 0% | N/A |
#2 | $0.4M | 5 | 0% | N/A |
#3 | $0.4M | 5 | 0% | N/A |
#4 | $0.4M | 5 | N/A | N/A |
#5 | $0.4M | 5 | 0% | N/A |